327 related articles for article (PubMed ID: 34440821)
1. The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis.
Henderson J; Dayalan Naidu S; Dinkova-Kostova AT; Przyborski S; Stratton R; O Reilly S
Cells; 2021 Aug; 10(8):. PubMed ID: 34440821
[TBL] [Abstract][Full Text] [Related]
2. 4-Octyl Itaconate Activates Nrf2 Signaling to Inhibit Pro-Inflammatory Cytokine Production in Peripheral Blood Mononuclear Cells of Systemic Lupus Erythematosus Patients.
Tang C; Wang X; Xie Y; Cai X; Yu N; Hu Y; Zheng Z
Cell Physiol Biochem; 2018; 51(2):979-990. PubMed ID: 30466076
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis.
Henderson J; Duffy L; Stratton R; Ford D; O'Reilly S
J Cell Mol Med; 2020 Dec; 24(23):14026-14038. PubMed ID: 33140521
[TBL] [Abstract][Full Text] [Related]
4. Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
Hseu YC; Yang TY; Li ML; Rajendran P; Mathew DC; Tsai CH; Lin RW; Lee CC; Yang HL
J Cell Mol Med; 2019 Feb; 23(2):775-788. PubMed ID: 30549180
[TBL] [Abstract][Full Text] [Related]
5. Immune-responsive gene 1 protects against liver injury caused by concanavalin A via the activation Nrf2/HO-1 pathway and inhibition of ROS activation pathways.
Yang W; Wang Y; Zhang P; Sun X; Chen X; Yu J; Shi L; Yin Y; Tao K; Li R
Free Radic Biol Med; 2022 Mar; 182():108-118. PubMed ID: 35231555
[TBL] [Abstract][Full Text] [Related]
6. Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response.
Sun KA; Li Y; Meliton AY; Woods PS; Kimmig LM; Cetin-Atalay R; Hamanaka RB; Mutlu GM
Elife; 2020 Apr; 9():. PubMed ID: 32255424
[TBL] [Abstract][Full Text] [Related]
7. Four-octyl itaconate activates Nrf2 cascade to protect osteoblasts from hydrogen peroxide-induced oxidative injury.
Zheng Y; Chen Z; She C; Lin Y; Hong Y; Shi L; Zhang Y; Cao P; Xu X
Cell Death Dis; 2020 Sep; 11(9):772. PubMed ID: 32943614
[TBL] [Abstract][Full Text] [Related]
8. Itaconate alleviates anesthesia/surgery-induced cognitive impairment by activating a Nrf2-dependent anti-neuroinflammation and neurogenesis via gut-brain axis.
Kong X; Lyu W; Lin X; Lin C; Feng H; Xu L; Shan K; Wei P; Li J
J Neuroinflammation; 2024 Apr; 21(1):104. PubMed ID: 38649932
[TBL] [Abstract][Full Text] [Related]
9. The
Kavian N; Mehlal S; Jeljeli M; Saidu NEB; Nicco C; Cerles O; Chouzenoux S; Cauvet A; Camus C; Ait-Djoudi M; Chéreau C; Kerdine-Römer S; Allanore Y; Batteux F
Front Immunol; 2018; 9():1896. PubMed ID: 30177933
[TBL] [Abstract][Full Text] [Related]
10. 4-Octyl itaconate alleviates renal ischemia reperfusion injury by ameliorating endoplasmic reticulum stress via Nrf2 pathway.
Li XK; Yang HJ; Du SH; Zhang B; Li LY; Li SN; Liu CC; Ma Y; Yu JB
Exp Biol Med (Maywood); 2023 Dec; 248(23):2408-2420. PubMed ID: 38158612
[TBL] [Abstract][Full Text] [Related]
11. Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling.
Sun X; Zhang B; Pan X; Huang H; Xie Z; Ma Y; Hu B; Wang J; Chen Z; Shi P
FASEB J; 2019 Nov; 33(11):12929-12940. PubMed ID: 31490085
[TBL] [Abstract][Full Text] [Related]
12. 4-Octyl itaconate suppresses the osteogenic response in aortic valvular interstitial cells via the Nrf2 pathway and alleviates aortic stenosis in mice with direct wire injury.
Peng X; Su S; Zeng J; Xie K; Yang X; Xian G; Xiao Z; Zhu P; Zheng S; Xu D; Zeng Q
Free Radic Biol Med; 2022 Aug; 188():404-418. PubMed ID: 35787451
[TBL] [Abstract][Full Text] [Related]
13. Four-octyl itaconate activates Keap1-Nrf2 signaling to protect neuronal cells from hydrogen peroxide.
Liu H; Feng Y; Xu M; Yang J; Wang Z; Di G
Cell Commun Signal; 2018 Nov; 16(1):81. PubMed ID: 30442144
[TBL] [Abstract][Full Text] [Related]
14. Itaconate Suppresses Formation of Neutrophil Extracellular Traps (NETs): Involvement of Hypoxia-Inducible Factor 1α (Hif-1α) and Heme Oxygenase (HO-1).
Burczyk G; Cichon I; Kolaczkowska E
Front Immunol; 2022; 13():864638. PubMed ID: 35837403
[TBL] [Abstract][Full Text] [Related]
15. Chelerythrine Ameliorates Pulmonary Fibrosis via Activating the Nrf2/ARE Signaling Pathway.
Peng L; Wen L; Shi Q; Gao F; Huang B; Wang C
Cell Biochem Biophys; 2021 Jun; 79(2):337-347. PubMed ID: 33580396
[TBL] [Abstract][Full Text] [Related]
16. 4-octyl itaconate alleviates cisplatin-induced ferroptosis possibly via activating the NRF2/HO-1 signalling pathway.
Zhang L; Song W; Li H; Cui X; Ma J; Wang R; Xu Y; Li M; Bai X; Wang D; Sun H; Lu Z
J Cell Mol Med; 2024 Apr; 28(7):e18207. PubMed ID: 38506087
[TBL] [Abstract][Full Text] [Related]
17. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative.
Wei J; Zhu H; Lord G; Bhattachayya M; Jones BM; Allaway G; Biswal SS; Korman B; Marangoni RG; Tourtellotte WG; Varga J
Transl Res; 2017 May; 183():71-86.e1. PubMed ID: 28027929
[TBL] [Abstract][Full Text] [Related]
19. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition.
Wu YX; Zhang YR; Jiang FJ; He S; Zhang YL; Chen D; Tong Y; Nie YJ; Pang QF
Inflamm Res; 2023 Jun; 72(6):1133-1145. PubMed ID: 37169970
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway.
Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A
Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
